Affordable Access

deepdyve-link
Publisher Website

Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19).

Authors
  • Surapat, Bhitta1
  • Sungkanuparph, Somnuek2
  • Kirdlarp, Suppachok2
  • Lekpittaya, Nantaporn1
  • Chunnguleum, Krittaya3
  • 1 Department of Pharmacy, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. , (Thailand)
  • 2 Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand. , (Thailand)
  • 3 Department of Pharmacy, Faculty of Medicine Ramathibodi Hospital, Chakri Naruebodindra Medical Institute, Mahidol University, Samut Prakan, Thailand. , (Thailand)
Type
Published Article
Journal
Journal of Clinical Pharmacy and Therapeutics
Publisher
Wiley (Blackwell Publishing)
Publication Date
Oct 21, 2020
Identifiers
DOI: 10.1111/jcpt.13293
PMID: 33085800
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Clinical pharmacists actively participate in patient care via patients' medication use. Yet the setting of Coronavirus Disease 2019 (COVID-19) limits patient contact with healthcare personnel. We aimed to review the services provided and drug-related problems detected using telemonitoring methods to guide clinical pharmacists in providing service in treating COVID-19 patients. At a tertiary care hospital in Thailand, clinical pharmacists provided pharmaceutical care services for COVID-19 patients via telemonitoring using the hospital's computerized physician order entry system. The pharmacists were able to provide therapeutic drug monitoring services, especially for anticoagulants. Many patients were considered special populations, with individualized requirements for drug dosing. Some adverse drug reactions were observed. Drug-related problems were mostly related to medication use in critically ill patients. Telemonitoring is a viable method for clinical pharmacists to provide pharmaceutical care and meet the challenges posed by treating patients with COVID-19. © 2020 John Wiley & Sons Ltd.

Report this publication

Statistics

Seen <100 times